159 related articles for article (PubMed ID: 30720053)
1. Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo.
Yang X; Yang T; Li J; Yang R; Qi S; Zhao Y; Li L; Li J; Zhang X; Yang K; Xu Y; Liu C
Int J Mol Med; 2019 Apr; 43(4):1611-1622. PubMed ID: 30720053
[TBL] [Abstract][Full Text] [Related]
2. Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo.
Yang X; Ding H; Qin Z; Zhang C; Qi S; Zhang H; Yang T; He Z; Yang K; Du E; Liu C; Xu Y; Zhang Z
Oxid Med Cell Longev; 2016; 2016():4156075. PubMed ID: 27781075
[TBL] [Abstract][Full Text] [Related]
3. Organic Selenium Alleviated the Formation of Ethylene Glycol-Induced Calcium Oxalate Renal Calculi by Improving Osteopontin Expression and Antioxidant Capability in Dogs.
Liu Y; Xu H; Zhong W; Shen Q; Zhuang T; Huang K
Biol Trace Elem Res; 2015 Dec; 168(2):392-400. PubMed ID: 26018495
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition.
Tsuji H; Shimizu N; Nozawa M; Umekawa T; Yoshimura K; De Velasco MA; Uemura H; Khan SR
Urolithiasis; 2014 Jun; 42(3):195-202. PubMed ID: 24619192
[TBL] [Abstract][Full Text] [Related]
5. Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.
Hong SH; Lee HJ; Sohn EJ; Ko HS; Shim BS; Ahn KS; Kim SH
Pharmacol Rep; 2013; 65(4):970-9. PubMed ID: 24145091
[TBL] [Abstract][Full Text] [Related]
6. Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.
Lee HJ; Jeong SJ; Park MN; Linnes M; Han HJ; Kim JH; Lieske JC; Kim SH
Biol Pharm Bull; 2012; 35(4):539-44. PubMed ID: 22466558
[TBL] [Abstract][Full Text] [Related]
7. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.
Hirose Y; Yasui T; Taguchi K; Fujii Y; Niimi K; Hamamoto S; Okada A; Kubota Y; Kawai N; Itoh Y; Tozawa K; Sasaki S; Kohri K
Urolithiasis; 2013 Aug; 41(4):279-94. PubMed ID: 23754513
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Melatonin on Ethylene Glycol-induced Nephrolithiasis: Role on Osteopontin mRNA Gene Expression.
Sener TE; Sener G; Cevik O; Eker P; Cetinel S; Traxer O; Tanidir Y; Akbal C
Urology; 2017 Jan; 99():287.e9-287.e15. PubMed ID: 27717860
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of female sex hormones on urinary stone formation in rats.
Iguchi M; Takamura C; Umekawa T; Kurita T; Kohri K
Kidney Int; 1999 Aug; 56(2):479-85. PubMed ID: 10432386
[TBL] [Abstract][Full Text] [Related]
10. [Multifunctional character of osteopontin and strategy for clinical applications].
Tsuji H; Umekawa T; Uemura H
Hinyokika Kiyo; 2011 Jan; 57(1):49-54. PubMed ID: 21304262
[TBL] [Abstract][Full Text] [Related]
11. Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.
Lazar M; Sullivan J; Chipitsyna G; Aziz T; Salem AF; Gong Q; Witkiewicz A; Denhardt DT; Yeo CJ; Arafat HA
Surgery; 2010 Aug; 148(2):298-309. PubMed ID: 20579680
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits TGF-beta 1-induced MCP-1 expression through BAMBI-mediated suppression of MEK/ERK1/2 signalling.
Liang D; Song Z; Liang W; Li Y; Liu S
Nephrology (Carlton); 2019 Apr; 24(4):481-488. PubMed ID: 29934960
[TBL] [Abstract][Full Text] [Related]
13. Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity.
Li Y; McLaren MC; McMartin KE
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F605-15. PubMed ID: 20534866
[TBL] [Abstract][Full Text] [Related]
14. Astaxanthin modulates osteopontin and transforming growth factor β1 expression levels in a rat model of nephrolithiasis: a comparison with citrate administration.
Alex M; Sauganth Paul MV; Abhilash M; Mathews VV; Anilkumar TV; Nair RH
BJU Int; 2014 Sep; 114(3):458-66. PubMed ID: 24712822
[TBL] [Abstract][Full Text] [Related]
15. Interaction between osteopontin on madin darby canine kidney cell membrane and calcium oxalate crystal.
Yamate T; Kohri K; Umekawa T; Konya E; Ishikawa Y; Iguchi M; Kurita T
Urol Int; 1999; 62(2):81-6. PubMed ID: 10461108
[TBL] [Abstract][Full Text] [Related]
16. Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Sato M; Fujita K; Ito Y; Nomura S; Kohri K
Nephron; 2001 Feb; 87(2):170-6. PubMed ID: 11244313
[TBL] [Abstract][Full Text] [Related]
17. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Fujita K; Sato M; Sugimoto M; Iguchi M; Nomura S; Kohri K
Urol Res; 1999 Jun; 27(3):194-9. PubMed ID: 10422821
[TBL] [Abstract][Full Text] [Related]
18. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization and mRNA quantification of osteopontin and Tamm-Horsfall protein in canine renal tissue after potassium oxalate injection.
Mohamaden W; Wang H; Guan H; Meng X; Li J
BMC Vet Res; 2014 Mar; 10():70. PubMed ID: 24628885
[TBL] [Abstract][Full Text] [Related]
20. Renal osteopontin expression in experimental urolithiasis.
Yagisawa T; Chandhoke PS; Fan J; Lucia S
J Endourol; 1998 Apr; 12(2):171-6. PubMed ID: 9607445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
